Sri Lanka, April 30 -- British pharma giant AstraZeneca has admitted that its Covid vaccine can cause a rare side effect, The Telegraph (UK) has reported. Covishield can cause, in rare cases, a condition that leads to blot clots and low platelet count, the vaccine-maker has said in court documents.

Covishield, developed by AstraZeneca and Oxford University during the pandemic, was produced by the Serum Institute of India and widely administered in the country.

AstraZeneca is facing a class action lawsuit in the UK over claims that its vaccine caused deaths and severe injuries in several cases. Victims in as many as 51 cases in the UK High Court are seeking damages up to 100 million pounds.

Jamie Scott, the first complainant in the case...